- Home
- SNCR vs OKYO Comparison
SNCR vs OKYO Comparison
Compare SNCR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- OKYO
- Stock Information
- Founded
- SNCR 2000
- OKYO 2007
- Country
- SNCR United States
- OKYO United Kingdom
- Employees
- SNCR N/A
- OKYO N/A
- Industry
- SNCR EDP Services
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNCR Technology
- OKYO Health Care
- Exchange
- SNCR Nasdaq
- OKYO Nasdaq
- Market Cap
- SNCR 70.9M
- OKYO 85.0M
- IPO Year
- SNCR 2006
- OKYO 2022
- Fundamental
- Price
- SNCR $6.23
- OKYO $2.12
- Analyst Decision
- SNCR Strong Buy
- OKYO Strong Buy
- Analyst Count
- SNCR 1
- OKYO 1
- Target Price
- SNCR $13.00
- OKYO $7.00
- AVG Volume (30 Days)
- SNCR 62.9K
- OKYO 56.1K
- Earning Date
- SNCR 11-11-2025
- OKYO 07-18-2025
- Dividend Yield
- SNCR N/A
- OKYO N/A
- EPS Growth
- SNCR N/A
- OKYO N/A
- EPS
- SNCR N/A
- OKYO N/A
- Revenue
- SNCR $171,870,000.00
- OKYO N/A
- Revenue This Year
- SNCR $1.51
- OKYO N/A
- Revenue Next Year
- SNCR $5.43
- OKYO N/A
- P/E Ratio
- SNCR N/A
- OKYO N/A
- Revenue Growth
- SNCR 2.54
- OKYO N/A
- 52 Week Low
- SNCR $5.25
- OKYO $0.90
- 52 Week High
- SNCR $15.46
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- SNCR 51.19
- OKYO 34.71
- Support Level
- SNCR $5.41
- OKYO $2.06
- Resistance Level
- SNCR $6.27
- OKYO $2.17
- Average True Range (ATR)
- SNCR 0.32
- OKYO 0.14
- MACD
- SNCR 0.11
- OKYO -0.00
- Stochastic Oscillator
- SNCR 86.73
- OKYO 10.35
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.